| Open written options contracts as of October 31, 2024 were as follows: | |||||
| Description of Options | Number of Contracts | Contract Notional Amount | Strike Price(1) | Expiration Date | Value |
| Call Options(2) | |||||
| 3M Co. | (40) | $(580) | $145.00 | 11/15/24 | $(—) (3) |
| Advanced Micro Devices, Inc. | (9) | (153) | 170.00 | 11/15/24 | (—) (3) |
| Boston Scientific Corp. | (70) | (630) | 90.00 | 11/15/24 | (1) |
| Cadence Design Systems, Inc. | (8) | (260) | 325.00 | 11/15/24 | (1) |
| Eli Lilly & Co. | (9) | (810) | 900.00 | 11/15/24 | (4) |
| GE Vernova, Inc. | (4) | (124) | 310.00 | 11/15/24 | (4) |
| General Electric Co. | (41) | (820) | 200.00 | 11/15/24 | (1) |
| Intuitive Surgical, Inc. | (15) | (825) | 550.00 | 11/15/24 | (1) |
| Netflix, Inc. | (5) | (418) | 835.00 | 11/15/24 | (—) (3) |
| O’Reilly Automotive, Inc. | (2) | (252) | 1,260.00 | 11/15/24 | (—) (3) |
| RTX Corp. | (47) | (635) | 135.00 | 11/15/24 | (—) (3) |
| Tesla, Inc. | (30) | (930) | 310.00 | 11/15/24 | (2) |
| Texas Instruments, Inc. | (30) | (667) | 222.50 | 11/15/24 | (1) |
| UnitedHealth Group, Inc. | (8) | (504) | 630.00 | 11/15/24 | (1) |
| Total Written Options | $(16) | ||||
| Footnote Legend: | |
| (1) Strike price not reported in thousands. | |
| (2) Exchange-traded options. | |
| (3) Amount is less than $500 (not in thousands). | |
| Total Value at October 31, 2024 | Level 1 Quoted Prices | Level 2 Significant Observable Inputs | Level 3 Significant Unobservable Inputs | ||||
| Assets: | |||||||
| Debt Instruments: | |||||||
| Convertible Bonds and Notes | $166,152 | $— | $166,152 | $— | |||
| Corporate Bonds and Notes | 56,451 | — | 56,451 | — | |||
| Equity Securities: | |||||||
| Convertible Preferred Stocks | 18,979 | 18,979 | — | — | |||
| Preferred Stock | 63 | — | — | 63 | |||
| Common Stocks | 75,249 | 75,187 | — | 62(1) | |||
| Warrant | 8 | — | — | 8 | |||
| Equity-Linked Notes | 3,623 | — | 1,620 | 2,003 | |||
| Money Market Mutual Fund | 5,867 | 5,867 | — | — | |||
| Total Assets | 326,392 | 100,033 | 224,223 | 2,136 | |||
| Liabilities: | |||||||
| Other Financial Instruments: | |||||||
| Written Options | (16) | (15) | (1) | — | |||
| Total Liabilities | (16) | (15) | (1) | — | |||
| Total Investments, Net of Written Options | $326,376 | $100,018 | $224,222 | $2,136 |
| (1) | Includes internally fair valued securities currently priced at zero ($0). |
| Total | Preferred Stock | Common stock | Warrants | Equity-Linked Notes | |||||
| Investments in Securities | |||||||||
| Balance as of January 31, 2024: | $ 1,988 | $ 63 | $ —(a) | $ —(a) | $ 1,925 | ||||
| Net realized gain (loss) | 316 | — | — | — | 316 | ||||
| Net change in unrealized appreciation (depreciation)(b) | 158 | — | 62 | 8 | 88 | ||||
| Purchases | 9,746 | — | — | — | 9,746 | ||||
| Sales(c) | (10,072) | — | — | — | (10,072) | ||||
| Balance as of October 31, 2024 | $ 2,136 | $ 63 | $ 62(a) | $ 8 | $ 2,003 |
| Investments in Securities – Assets | Ending Balance at October 31, 2024 | Valuation Technique Used | Unobservable Inputs | Input Values | Impact to Valuation from an Increase in Unobservable Inputs(a) | |||||
| Preferred Stock: | ||||||||||
| LiveStyle, Inc. Series B | $63 | Discounted cash flows liquidation approach | Discount rate
| 22.00% (21.66% - 22.40%) | Decrease | |||||
| Common Stocks: | ||||||||||
| CCF Holdings LLC | $51 | OPM and Last transaction | Volatility
| 44.01% (39.70% - 56.00%) | Increase | |||||
| CCF Holdings LLC Class M | $11 | OPM and Last transaction | Volatility
| 44.01% (39.70% - 56.00%) | Increase | |||||
| Warrant: | ||||||||||
| CCF Holdings LLC | $8 | Black-Scholes Model | Volatility
| 44.01% (39.70% - 56.00%) | Increase | |||||
| • | Level 1 – quoted prices in active markets for identical securities (security types generally include listed equities). |
| • | Level 2 – prices determined using other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, credit risk, etc.). |
| • | Level 3 – prices determined using significant unobservable inputs (including the investment adviser’s Valuation Committee’s own assumptions in determining the fair value of investments). |